home All News open_in_new Full Article

Las adquisiciones relacionadas con terapias para el alzhéimer se disparan a 14.285 millones de euros en lo que va de año

En 2025 se han cerrado dos operaciones que involucran a moléculas en desarrollo para tratar esta enfermedad. Más información: Lilly 'amenaza' a Eisai y Biogen en el mercado del alzhéimer: EEUU apoya la aprobación de su terapia


today 18 h. ago attach_file Science

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Science
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Science
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1977718331
Add Watch Country

arrow_drop_down